COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 142 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q3 2020. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $425,142 | +6.3% | 19,022 | +2.2% | 0.00% | +50.0% |
Q2 2023 | $399,907 | -9.2% | 18,609 | +1.4% | 0.00% | -33.3% |
Q1 2023 | $440,217 | +3.9% | 18,350 | +0.4% | 0.00% | 0.0% |
Q4 2022 | $423,818 | +42.2% | 18,268 | -1.9% | 0.00% | +50.0% |
Q3 2022 | $298,000 | -8.6% | 18,619 | +1.2% | 0.00% | 0.0% |
Q2 2022 | $326,000 | -19.1% | 18,405 | -7.0% | 0.00% | 0.0% |
Q1 2022 | $403,000 | +2.8% | 19,780 | -5.8% | 0.00% | 0.0% |
Q4 2021 | $392,000 | -10.3% | 20,992 | -5.1% | 0.00% | 0.0% |
Q3 2021 | $437,000 | -19.1% | 22,118 | -3.2% | 0.00% | 0.0% |
Q2 2021 | $540,000 | -0.6% | 22,859 | -0.2% | 0.00% | 0.0% |
Q1 2021 | $543,000 | +35.8% | 22,896 | +14.7% | 0.00% | +100.0% |
Q4 2020 | $400,000 | -6.3% | 19,955 | -2.8% | 0.00% | -50.0% |
Q3 2020 | $427,000 | +16.3% | 20,528 | -2.2% | 0.00% | 0.0% |
Q2 2020 | $367,000 | +18.0% | 20,994 | +10.3% | 0.00% | 0.0% |
Q1 2020 | $311,000 | -24.9% | 19,026 | -5.5% | 0.00% | 0.0% |
Q4 2019 | $414,000 | +77.7% | 20,125 | -0.8% | 0.00% | +100.0% |
Q3 2019 | $233,000 | -13.4% | 20,295 | -0.7% | 0.00% | 0.0% |
Q2 2019 | $269,000 | -4.9% | 20,436 | +9.2% | 0.00% | 0.0% |
Q1 2019 | $283,000 | -14.8% | 18,713 | -3.1% | 0.00% | 0.0% |
Q4 2018 | $332,000 | +15.7% | 19,320 | -0.8% | 0.00% | 0.0% |
Q3 2018 | $287,000 | -37.1% | 19,468 | +1.8% | 0.00% | -50.0% |
Q2 2018 | $456,000 | +11.5% | 19,118 | +19.4% | 0.00% | +100.0% |
Q1 2018 | $409,000 | +31.1% | 16,017 | -5.1% | 0.00% | 0.0% |
Q4 2017 | $312,000 | +96.2% | 16,879 | +11.1% | 0.00% | 0.0% |
Q3 2017 | $159,000 | -9.7% | 15,198 | +8.1% | 0.00% | 0.0% |
Q2 2017 | $176,000 | +76.0% | 14,061 | +41.3% | 0.00% | – |
Q1 2017 | $100,000 | -17.4% | 9,948 | +27.8% | 0.00% | – |
Q4 2016 | $121,000 | -99.9% | 7,785 | -0.3% | 0.00% | -100.0% |
Q3 2016 | $150,344,000 | +62.8% | 7,806 | +0.1% | 0.00% | – |
Q2 2016 | $92,371,000 | +30.1% | 7,795 | +99.6% | 0.00% | – |
Q1 2016 | $71,000,000 | -33.6% | 3,906 | 0.0% | 0.00% | – |
Q4 2015 | $107,000,000 | +122888.5% | 3,906 | -0.2% | 0.00% | – |
Q3 2015 | $87,000 | -99.9% | 3,913 | +0.1% | 0.00% | – |
Q2 2015 | $69,737,000 | – | 3,909 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rubric Capital Management LP | 2,606,500 | $51,452,000 | 1.44% |
Camber Capital Management LP | 2,000,000 | $39,480,000 | 1.22% |
Eventide Asset Management | 2,629,593 | $51,908,000 | 0.68% |
GREAT POINT PARTNERS LLC | 121,342 | $2,395,000 | 0.56% |
RICE HALL JAMES & ASSOCIATES, LLC | 753,038 | $14,865,000 | 0.55% |
Values First Advisors, Inc. | 41,773 | $825,000 | 0.53% |
CLARK ESTATES INC/NY | 183,800 | $3,628,000 | 0.52% |
EMERALD MUTUAL FUND ADVISERS TRUST | 710,398 | $14,023,000 | 0.48% |
EMERALD ADVISERS, LLC | 590,256 | $11,652,000 | 0.42% |
ACORN FINANCIAL ADVISORY SERVICES INC /ADV | 68,812 | $1,358,000 | 0.42% |